Vivos in The News Explore The Stories LeadershipFinancial Results & SEC FilingsStock PricingGovernanceNews + Events Menu LeadershipFinancial Results & SEC FilingsStock PricingGovernanceNews + Events Q2 Earnings Release, 2024 Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance Vivos Reports First Quarter 2024 Financial Results & Provides Operational Update Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call Load More
Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model
Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
